HER2/Neu Positive Recruiting Phase 1 Trials for Regramostim (DB05386)

IndicationStatusPhase
DBCOND0037939 (HER2/Neu Positive)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04144023A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In SituTreatment